LeMaitre Vascular Total Assets 2007-2018 | LMAT

LeMaitre Vascular total assets from 2007 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
LeMaitre Vascular Annual Total Assets
(Millions of US $)
2017 $126
2016 $102
2015 $91
2014 $81
2013 $70
2012 $63
2011 $60
2010 $63
2009 $57
2008 $54
2007 $61
2006 $57
2005 $25
LeMaitre Vascular Quarterly Total Assets
(Millions of US $)
Q3 2018 $144
Q2 2018 $137
Q1 2018 $129
Q4 2017 $126
Q3 2017 $121
Q2 2017 $112
Q1 2017 $107
Q4 2016 $102
Q3 2016 $101
Q2 2016 $96
Q1 2016 $93
Q4 2015 $91
Q3 2015 $87
Q2 2015 $83
Q1 2015 $80
Q4 2014 $81
Q3 2014 $84
Q2 2014 $81
Q1 2014 $69
Q4 2013 $70
Q3 2013 $67
Q2 2013 $64
Q1 2013 $63
Q4 2012 $63
Q3 2012 $61
Q2 2012 $60
Q1 2012 $59
Q4 2011 $60
Q3 2011 $63
Q2 2011 $62
Q1 2011 $61
Q4 2010 $63
Q3 2010 $61
Q2 2010 $58
Q1 2010 $57
Q4 2009 $57
Q3 2009 $56
Q2 2009 $54
Q1 2009 $51
Q4 2008 $54
Q3 2008 $54
Q2 2008 $56
Q1 2008 $57
Q4 2007 $61
Q3 2007 $57
Q2 2007 $56
Q1 2007 $56
Q4 2006 $57
Q2 2006 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.492B $0.106B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $131.725B 26.04
Medtronic (MDT) Ireland $124.003B 18.10
Stryker (SYK) United States $69.357B 25.46
Boston Scientific (BSX) United States $55.158B 26.93
Baxter (BAX) United States $39.096B 24.09
Zimmer Biomet Holdings (ZBH) United States $25.203B 16.17
Smith & Nephew SNATS (SNN) United Kingdom $16.703B 0.00
ResMed (RMD) United States $14.294B 27.11
Canopy Growth (CGC) Canada $10.770B 0.00
Bio-Rad Laboratories (BIO) United States $8.091B 51.74
Hill-Rom Holdings (HRC) United States $6.945B 21.48
Aurora Cannabis (ACB) Canada $6.920B 49.50
Perrigo (PRGO) Ireland $6.732B 10.22
ICU Medical (ICUI) United States $5.180B 28.86
Insulet (PODD) United States $5.177B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.529B 0.00
Haemonetics (HAE) United States $4.482B 39.76
Agios Pharmaceuticals (AGIO) United States $3.370B 0.00
Hutchison China MediTech (HCM) China $3.317B 0.00
Neogen (NEOG) United States $3.262B 50.11
NuVasive (NUVA) United States $2.949B 27.43
Quidel (QDEL) United States $2.670B 24.08
National Vision Holdings (EYE) United States $2.583B 49.97
Aphria (APHA) $2.429B 107.89
NxStage Medical (NXTM) United States $1.977B 0.00
AtriCure (ATRC) United States $1.267B 0.00
Phibro Animal Health (PAHC) United States $1.231B 17.70
VAREX IMAGING (VREX) United States $1.213B 23.75
Cardiovascular Systems (CSII) United States $1.191B 854.75
HEXO (HEXO) $1.180B 0.00
MacroGenics (MGNX) United States $0.936B 0.00
Cerus (CERS) United States $0.886B 0.00
PetIQ (PETQ) United States $0.833B 21.60
Surmodics (SRDX) United States $0.773B 112.39
Lantheus Holdings (LNTH) United States $0.737B 19.96
Meridian Bioscience (VIVO) United States $0.728B 21.70
Evolus (EOLS) United States $0.725B 0.00
NanoString Technologies (NSTG) United States $0.718B 0.00
OraSure Technologies (OSUR) United States $0.707B 31.16
Omeros (OMER) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.624B 20.02
Quanterix (QTRX) United States $0.505B 0.00
Owens & Minor (OMI) United States $0.494B 6.84
Insys Therapeutics (INSY) United States $0.418B 0.00
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.322B 435.25
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.293B 0.00
Vapotherm (VAPO) United States $0.285B 0.00
Bovie Medical (APYX) United States $0.281B 0.00
Cytosorbents (CTSO) United States $0.259B 0.00
Rockwell Medical (RMTI) United States $0.253B 0.00
Zynex (ZYXI) United States $0.170B 16.42
Surface Oncology (SURF) United States $0.147B 0.00
Fonar (FONR) United States $0.146B 7.79
Chembio Diagnostics (CEMI) United States $0.116B 0.00
Chimerix (CMRX) United States $0.097B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.085B 0.00
InfuSystems Holdings (INFU) United States $0.083B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.064B 17.80
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.022B 0.00
Myomo (MYO) United States $0.017B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.29